The present invention relates to novel pyrimido[1,6-a]pyrimidin-6(2H)-one compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
本发明涉及一种新型的抑制Lp-P
LA2活性的
嘧啶并[1,6-a]
嘧啶-6(2H)-
酮化合物,以及其制备方法、含有它们的组合物和它们在治疗与Lp-P
LA2活性相关的疾病,例如动脉粥样硬化、阿尔茨海默病等方面的用途。